Literature DB >> 19899558

[Diabetus mellitus and pregnancy].

Adriana Neckell1, M Munteanu.   

Abstract

OBJECTIVE: The evaluation of diabetic retinopathy during pregnancy.
MATERIAL AND METHODS: Retrospective study regarding 16 pregnant patients, with type 1 diabetes mellitus and variable retinal changes before the pregnancy: without retinal changes (5 cases), minimal diabetic retinopathy (7 cases), severe diabetic retinopathy (3 cases), proliferative diabetic retinopathy with panphotocoagulation before the pregnancy (1 case). The patients had a complete general and ocular investigation.
RESULTS: The patients without retinal changes were not influenced by pregnancy; the patients with minimal changes presented an aggravation of the diabetic retinopathy with an amelioration post-partum in 3 from the 7 cases; the patients with severe diabetic retinopathy suffered an aggravation in 1 from the 3 cases; the patients with proliferative diabetic retinopathy with panphotocoagulation before the pregnancy did not present any important changes during pregnancy.
CONCLUSIONS: The pregnancy represents a risk factor in the evolution of retinal changes in diabetic patients. The monitoring of the retinal changes and of the patients during the pregnancy is strongly recommended.

Entities:  

Mesh:

Year:  2009        PMID: 19899558

Source DB:  PubMed          Journal:  Oftalmologia        ISSN: 1220-0875


  2 in total

1.  Retinopathy and risk factors in diabetic patients from Al-Madinah Al-Munawarah in the Kingdom of Saudi Arabia.

Authors:  Mohamed F El-Bab; Nashaat Shawky; Ali Al-Sisi; Mohamed Akhtar
Journal:  Clin Ophthalmol       Date:  2012-02-17

2.  Association between the Number of Childbirths and the Progress of Atherosclerosis among Women with Diabetes: A Cohort Study Based on Chinese Population.

Authors:  Jie Wang; Yu Pei; Kang Chen; Wenhua Yan; Anping Wang; Yijun Li; Jia Li; Haibing Wang; Ping An; Linxi Zhang; Yingnan Ye; Xinye Jin; Guang Ning; Yiming Mu; Weijun Gu
Journal:  Int J Endocrinol       Date:  2019-01-27       Impact factor: 3.257

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.